Showing 9441-9450 of 10718 results for "".
Take 5
https://practicaldermatology.com/columns/take-5/0408_pd-take-5-pdf/22705/Take 5Analyzing Recent Deuruxolitinib Data
https://practicaldermatology.com/videos/skin-minute/analyzing-recent-deuruxolitinib-data/57165/Arash Mostaghimi, MD, MPH, FAAD, Vice Chair of Clinical Trials and Innovation for the Brigham & Women's Hospital Department of Dermatology, discusses reently released data on deuruxolitinib for the treatment of alopecia areata.The Emergence of Targeted Therapies for Prurigo Nodularis
https://practicaldermatology.com/programs/dermatology-hub-neuroimmune-network/the-emergence-of-targeted-therapies-for-prurigo-nodularis/48775/Christopher Bunick, MD, FAAD, discusses the importance of acknowledging prurigo nodularis as a distinct disease with its own molecular and transcriptomic features distinguishing it from atopic dermatitis, and how targeting the IL-31 receptor can change the game.DERM2020 Exhibitor Reaction: Brett Fair, EPI Health
https://practicaldermatology.com/conferences/dermatology-education-foundation-derm-2020/derm2020-exhibitor-reaction-brett-fair-epi-health/19847/Brett Fair of EPI Health, a DERM2020 exhibitor, tells us what he thinks of the new virtual meeting world and how DEF is dominating it for dermatology!COVID-19 Impact: iPledge and Isotretinoin Prescribing
https://practicaldermatology.com/topics/acne-rosacea/covid-19-impact-ipledge-and-isotretinoin-prescribing/19763/For patients on isotretinoin, complying with the iPledge program while treating patients virtually can be challenging. Joshua Zeichner, MD discusses new FDA guidance that allows female patients to take OTC pregnancy tests in order to continue treatment. He also discusses when patients do and do notPractical Dermatology March 2026: Page-Turner Format
https://practicaldermatology.com/issues/march-2026/practical-dermatology-march-2026-page-turner-format/56412/Patient Perspectives on Unmet Needs in Topical Psoriasis Therapy
https://practicaldermatology.com/issues/january-february-2025/patient-perspectives-on-unmet-needs-in-topical-psoriasis-therapy/32972/Despite the advantages of topical treatment, nonadherence (including overuse and underuse) affects up to 50% of patients, and therapy overuse is often incited by the desire for rapid clearance, ineffectiveness, and unclear instructions.Eyes Have It: Bloodless Blephs and More
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/eyes-have-it-bloodless-blephs-and-more/18728/Demand for treatments around the eye continue to grow; patients want big results but little downtime. Dr. Niamtu discusses his "bloodless bleph" and other uses for fillers and toxins.COVID-19 Impact: Virtual Care for Young Patients
https://practicaldermatology.com/topics/practice-management/covid-19-impact-virtual-care-for-young-patients/19765/With most dermatology practices closing their doors during the COVID-19 pandemic, telemedicine is emerging as an effective option for patient care. Peter Lio, MD offers tips for overcoming technology difficulties and enhancing communication during teleconsults. He also offers insights into how he isThe Business of Dermatology
https://practicaldermatology.com/topics/practice-management/the-business-of-dermatology/19725/Are you a dermatologist who runs a practice, or a business owner who happens to be a dermatologist? Robert Rullo challenges clinicians to rethink how they approach running their practice.